Action 6H90 HEALWELL AI INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Communiqués Healwell AI Inc. Börse Stuttgart

Actions

6H90

CA42249X1006

Temps réel estimé Tradegate
Autres places de cotation
 16:31:18 26/06/2024 		Varia. 5j. Varia. 1 janv.
1,573 EUR -0,13% Graphique intraday de Healwell AI Inc. -14,86% +221,43%
13/06 Healwell AI accepte d'acheter BioPharma Services pour 11,9 millions de dollars afin d'élargir son offre de recherche clinique MT
11/06 Healwell AI accepte d'acheter VeroSource Solutions pour 24,5 millions de dollars afin d'ajouter sa plateforme d'interopérabilité des données de santé basée sur l'informatique en nuage MT

Communiqués

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
HEALWELL AI Announces Strategic Investment in xAI to Accelerate Development of Healthcare Focused Large Language Models That Benefit from xAI Developer Ecosystem
NE
HEALWELL AI Announces Voting Results of 2024 Annual General Meeting of its Shareholders
NE
HEALWELL AI's Pentavere Demonstrates Its DARWEN AI System Can Support Earlier Detection of Radiation Related Toxicities in Cancer Patients for Preventative Care
NE
HEALWELL AI to Acquire BioPharma, One of Canada's Largest CROs, to Expand and AI-Enable Clinical Research Offerings
NE
HEALWELL AI to Acquire VeroSource Solutions and its Cloud-based Health Data Interoperability Platform to Help Large Enterprises Adopt AI-Powered Population Health Capabilities
GL
HEALWELL AI’s Pentavere Announces Partnership with Takeda to Support Rare Disease Real-World Evidence Analysis for Patients living with Hereditary Angioedema
GL
HEALWELL AI Appoints Anthony Lam as New Chief Financial Officer
GL
HEALWELL AI Closes Upsized $20 Million Bought Deal Offering
GL
HEALWELL AI’s Pentavere Partners with Sunnybrook and Successfully Demonstrates its AI Powered Clinician Co-pilot System Can Improve Cancer Staging in Prestigious Peer-Reviewed Medical Journal
GL
HEALWELL AI Participates in Leading-Edge Research on Chronic Kidney Disease Highlighting the Potential of its AI Powered Clinical Co-Pilot
GL
HEALWELL AI Reports Q1-2024 Financial Results
GL
HEALWELL AI to Announce Fiscal First Quarter 2024 Financial Results on May 14, 2024
GL
HEALWELL AI Inc. Announces Upsize of Bought Deal to Up to $20 Million
GL
HEALWELL AI Announces $16 Million Bought Deal Private Placement
GL
WELL Launches its Second-Generation AI powered Physician Co-pilot with Chronic Disease Detection Powered by HEALWELL AI
GL
HEALWELL Subsidiaries, Khure Health & Pentavere Research Group, to Participate and Present at Upcoming Globally Recognized Medical Conferences
GL
Emerging Markets Report: Follow the Leader
AQ
HEALWELL AI’s Pentavere Achieves Validation of Generative AI for Preventative Care Through Landmark Publication
GL
HEALWELL AI’s Pentavere Achieves Validation of Generative AI for Preventative Care Through Landmark Publication
AQ
HEALWELL AI shares major company milestones since its debut in Q4 of 2023
AQ
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action AIDX
  4. Action 6H90
  5. Actualités Healwell AI Inc.
  6. Communiqués